Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process.

Molecular Pharmaceutics
Purnendu K NayakKarthikan Rajagopal

Abstract

Maintenance of protein stability during manufacture, storage, and delivery is necessary for the successful development of a drug product. Herein, the utility of two compatible solutes-ectoine and hydroxyectoine-in stabilizing a model protein labeled Fab2 has been investigated. Specifically, the performance of ectoine and hydroxyectoine in stabilizing Fab2 in a spray-dried formulation at elevated temperature and after multiple freeze/thaw cycles has been compared with the performance of a formulation containing trehalose and a formulation containing no excipient as controls. In the solid state at 90 and 37 °C and in freeze concentrate systems, ectoine and hydroxyectoine suppress protein aggregation. Like trehalose, hydroxyectoine also limits N-terminal pyroglutamate formation in Fab2 in the solid state. The extent of protein stabilization is dependent on the excipient concentration in the formulation, but at a 1:1 excipient to protein mass ratio, hydroxyectoine is better than trehalose in stabilizing Fab2. The results presented here suggest that ectoine and hydroxyectoine are effective excipients for stabilizing therapeutic antibodies.

References

Aug 28, 1998·Molecular Microbiology·B Poolman, E Glaasker
Sep 14, 1999·Extremophiles : Life Under Extreme Conditions·S KnappE A Galinski
Dec 15, 2000·Biotechnology and Applied Biochemistry·M M AnderssonR Hatti-Kaul
Sep 11, 2002·Environmental Microbiology·Helena Santos, Milton S da Costa
Sep 26, 2006·Journal of Pharmaceutical Sciences·Wei WangSandeep Nema
Oct 27, 2007·Pharmaceutical Development and Technology·Bakul S BhatnagarMichael J Pikal
Feb 5, 1997·Biotechnology and Bioengineering·H R CostantinoA M Klibanov
Jan 30, 2009·Protein Science : a Publication of the Protein Society·Nishant Kumar Jain, Ipsita Roy
Jul 2, 2009·Journal of Pharmaceutical Sciences·Liuquan Lucy Chang, Michael J Pikal
Jul 6, 2010·Biotechnology Advances·José M PastorManuel Cánovas
Nov 9, 2010·Environmental Microbiology·Stephan Klähn, Martin Hagemann
Aug 19, 2011·Advances in Protein Chemistry and Structural Biology·D LoweD Christ
Aug 8, 2013·Journal of Immunotoxicology·Kirsty D RatanjiIan Kimber
Apr 29, 2014·Frontiers in Microbiology·Christoph TanneErwin A Galinski
Nov 16, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Faranak Salmannejad, Nastaran Nafissi-Varcheh
Feb 13, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Maarten A MensinkWouter L J Hinrichs
Sep 16, 2017·Physical Chemistry Chemical Physics : PCCP·Marc Benjamin HahnHeinz Sturm
Nov 12, 2017·Scientific Reports·M-A SchröterH J Kunte
Dec 1, 2017·Journal of Pharmaceutical Sciences·Peter Stärtzel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.